We describe a bioluminescent assay for gentamicin in serum that is applicable to the measurement of other aminoglycosides as well. The assay is based on the measurement ofresidual AlP withtheluciferase reaction afterincubation of the antibiotic witha piasmid-coded enzyme. Two aminoglycoside-inactivating enzymes were used: an adenylyltransferase and an acetyltransferase coupled to S-acetyl coenzymeA synthetase. We investi- 
ratio. Serum ATPases were inactivated at 60 #{176}C for 20 mm. The operating range of the assay was 0-15 mg of gentamicin per liter. The precision (CV)was 10.1% at a concentration of 2 mg/L and 1.1% at 10 mg/L. The method correlated well with a radio-enzymatic assay for mock unknown sera (r = 0.981). The results were available within 2 h. The margin between toxic and therapeutic doses being rather narrow, a rapid, reliable, and precise assay of these antibiotics is necessary on a routine basis, not only to prevent toxic concentrations but also to ensure adequate concentrations in biological fluids throughout the period of therapy.
AdditionalKeyphrases
Resistance to the aminoglycoside antibiotics in clinical isolates of bacteria is determined by the presence of plasmid-coded enzymes that modify the antibiotic by acetylation, adenylation (nucleotidylation), or phosphorylation (4, 5) .
Some of these plasmid-coded inactivating enzymes have been successfully used to assay aminoglycosides (6, 7) and chloramphenicol (8, 9) . Typically, the antibiotic to be assayed is incubated with the modifying enzyme and a labeled cosubstrate. The product of the reaction is then extracted or adsorbed on a paper disc and its radioactivity counted with a scintillation spectrometer. In the enzymatic assay for aminoglycosides we describe, we Because of the broad specificity of plasmid-coded enzymes (5, 14) , our approach is equally applicable to the measurement of severalother antibiotics. We measured the activity of AAC(3) by the 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) procedure described by Benveniste and Davies (17) . The reaction mixture contained 500 sL of a 300 mmol/L solution of Tris in 300 mmol/L maleate buffer at pH 7.8containing 0.8g DTNB per liter; 50 jzL of 2 mmolfL acetyl coenzyme A; 200 sL of 272 mg/L gentamicin;and AAC(3) to a finalvolume of 1 mL. The reaction started with the addition of AAC(3) after a 2-mm preincubation of the reaction mixture at 37 #{176}C. The blank solution contained all the above reagents except acetylcoenzyme A. The charge in absorbance at 412 nm was continuously monitored at 37 #{176}C with a Beckman Acta III spectrophotometer.
Materials and Methods

Reagents
One unit of AAC (3) To study the effectof heat denaturation on endogeneous serum ATPases, we performed the followingexperiment.A grossly hemolyzed serum, prepared by triturating the clot, was immediately centrifuged at 4 #{176}C. A 400-.tL aliquotof thishemolyzed serum served as a blank (0 mm at 60 #{176}C) and was transferredto a testtube containing 50 1.zLof distilled water at 0 #{176}C. Two milliliters of the same hemolyzed serum was then incubated at 60 #{176}C and 400-j.tL aliquots withdrawn after 5, 10, and 20 mm. We immediately transferred the aliquots to a test tube containing 50 zL of distilled water at 0 #{176}C to stop the denaturation reaction.
Residual ATPase activity was assayed at 37 #{176}C in each of the three inactivated samples and the blank as follows. These four samples were preincubated at 37 #{176}C. To each sample we added 50 tL of a 10 mg/L solutionof ATP and measured the ATP content with the Biometer at various periods during the 30-mm incubationat 37 #{176}C. Any ATP disappearance implies the presence of residualATPases.
On a routine basis, endogeneous serum ATPases were inactivated by incubating each specimen mm and determined theirATP content with the Biometer.
All assays were performed in duplicate.
Luciferase assay for gentamicin with the AAC(3)-ACS
system. To prepare the working reagent, we added at 0#{176}C 400 
Results
Allexperiments were performed with enzyme preparations that had a specific activityof 36 U/g of protein forAAD(2") and 3000 U/g of protein for AAC (3) . Enzyme activityin the crude extractdifferedmarkedly forthe two bacterial strains we have used; we obtained 50 mU of AAD(2") per gram of bacteria from E. coli W677/HJR 76.2 and 11 U of AAC (3) per grain of E. coli C600/JR 88, a 220-fold difference. The stability of AAC(3) was much greater than that of AAD(2"), with no loss of activity observed when kept for 4 months at 4 #{176}C in glycerol;AAD(2") losthalf itsactivityunder the same conditions.
Our first attempts to measure gentamicin by bioluminescence in mock unknowns with the AAD(2") or the AAC (3) were totally unsuccessful. We had previously determined the concentrations of both ATP and ATPases in several human sera, but when 10 tL of non-hemolyzed human serum was injected directly in the Biometer, we could not detect any ATP present. Values near 1 smol of ATP per liter were measured ingrossly hemolyzed serum, but ATP concentrationdecreased rapidly to 0 after15 mm at 25 #{176}C. We detected ATPase activitynear 0.15 U/L in hemolyzed sera and found some enzyme activity in many nonhemolyzed sera. It was soon evident to us that ATPases rather than ATP could interfere with a luciferase assay for aminoglycosides in serum and that the ATPases should be inactivated.
The effectof heat denaturation at 60 #{176}C on ATPases is presented in Figure 1 .When ATP was added to a grosslyhemolyzed serum previously incubated 20 mm at 60 #{176}C, the concentration of ATP remained virtually constant. Incubations of Sand 10 mm at 60#{176}C were not sufficient to inactivate all endogeneous ATPases.
Luciferase Assay for Gentamicin with AAD(2") AAD(2") uses ATP as a cosubstrate. After incubation with the enzyme and a rate-limiting concentration of aminoglycoside,the decrease in ATP should be proportional to the amount of antibioticpresent in the reaction mixture. We therefore devised a simple assay system for the measurement of gentamicin with the luciferase reaction involving
AAD(2").
The ATP/gentamicin ratiogreatlyaffects the initial enzymatic velocity of the adenylation reaction ( Figure 2 ). Initial velocity continues to increase even at a mass ratio of 30. Because of this unfavorable requirement, a mass ratio of at least 10 must be used to favor the rapid conversion of gentamicin with a reasonable enzyme concentration.Too high a ratio would be detrimental, however, because changes in ATP concentration would become almost negligible when compared to the high initial ATP value.
A typical standard curve for gentamicin in serum assayed with AAD(2") is shown in Figure 3 . The change in luminescence with concentration of gentamicin (mg/L) is only -0.07. The assay lacks sensitivity and has poor precision.
Luciferase Assay for Gentamicin with AAC(3)
The coupling of ACS to AAC(3) proved very successful. Reduced coenzymeA produced by the acetylatingenzyme is recycled to acetyl coenzyme A in the presence of ATP and Within-run repeatability was estimated by measuring the same mock unknown 16 times at concentrations of 2, 5,and AAC(3) could also be used to assay sisomicin because the enzyme acetylates this compound readily (14) . We have suc-cessfully measured by bioluminescence amikacin in serum with a different acetyltransferase, a 6-N-acetyltransferase (17) , coupling the reaction to ACS (authors' unpublished results). This latter enzyme would also allow the measurement of kanamycin, tobramycin, netylmicin, and neomycin (14) .
Discussion
Our experience with the production and utilization of AAC(3) and AAD(2") is similar to that of Williams et al. (18) . The adenylating enzyme is recovered in low yield and is very unstable. Furthermore, a large ATP/gentamicin ratio is required to avoid the need for high enzyme concentrations.
In contrast to the findings of Goldman and Northrop (10), AAD was not stable in our hands. However, AAC(3) is obtained in high yield and is very stable. Its use with ACS proved very successful, and we report the first luciferase assay for an aminoglycoside with the use of plasmid-coded enzymes. Bioassays for gentamicin based on the determination of total ATP (19) , intracellular ATP (20) , or extracellular ATP (21) in bacterial cultures exposed to standard gentamicin concentrations and to serum specimens have been published. The luciferase assay for aminoglycosides we have described combines the rapidity of the luciferase assay of ATP with the applicability to several antibiotics. Because aminoglycosides are not administered simultaneously to patients, the broad specificity of plasmid-coded enzymes allows the measurement of many aminoglycosides with use of the same reagents, even in the presence of other antibiotics frequently used in combination during the antibiotherapy (14) . The coupling of ACS to the very stable chloramphenicol acetyltransferase would allow the measurement of chloramphenicol and thiamphenicol in biological fluids (8) .
The luciferase assay is simple. Only one incubation is required, once the endogeneous serum ATPases have been inactivated. The procedure correlated well (r = 0.981) with a radioenzymatic assay for gentamicin. The results are available within 2 h. Only 50 jL of serum is required and the technique does not require radioactive chemicals. This approach lends itself well to automation, an improvement that would greatly increase precision at low concentrations of antibiotic.
